Search research articles
Contact Us
Filters
Showing results (381-390 of 706) with videos related to
Page
of 71
Sort By:
Circulation
|
April 17, 2002
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide
Marc S Sabatine, David A Morrow, James A de Lemos, et al.
The American Journal of Cardiology
|
October 29, 2005
Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial)
Jocelyn Dupuis, Jean-Claude Tardif, Jean-Lucien Rouleau, et al.
American Heart Journal
|
May 16, 2016
Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial
Yuichi J Shimada, Christopher P Cannon, Yuyin Liu, et al.
Clinical Cardiology
|
June 15, 2021
Kidney outcomes using a sustained ≥40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trials
David Z I Cherney, Samuel Dagogo-Jack, Darren K McGuire, et al.
Sleep & Breathing = Schlaf & Atmung
|
May 20, 2022
Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial
Brian S Wojeck, Silvio E Inzucchi, Ian J Neeland, et al.
The American Journal of Cardiology
|
April 26, 2008
Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy
C Michael Gibson, Yuri B Pride, Jacqueline L Buros, et al.
Journal of the American Heart Association
|
October 30, 2018
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials
Antonio J Vallejo-Vaz, Henry N Ginsberg, Michael H Davidson, et al.
American Heart Journal
|
December 12, 2017
Association of insurance type with receipt of oral anticoagulation in insured patients with atrial fibrillation: A report from the American College of Cardiology NCDR PINNACLE registry
Celina M Yong, Yuyin Liu, Patricia Apruzzese, et al.
The American Journal of Cardiology
|
March 23, 2011
Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry)
Farhad Abtahian, Benjamin Olenchock, Fang-Shu Ou, et al.
Journal of the American Heart Association
|
August 9, 2021
What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry
Suzanne V Arnold, Christopher P Cannon, James A de Lemos, et al.
Page
of 71
Search research articles
Search
Showing results (381-390 of 706) with videos related to
Sort By:
Page
of 71
Circulation
|
April 17, 2002
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide
Marc S Sabatine, David A Morrow, James A de Lemos, et al.
The American Journal of Cardiology
|
October 29, 2005
Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial)
Jocelyn Dupuis, Jean-Claude Tardif, Jean-Lucien Rouleau, et al.
American Heart Journal
|
May 16, 2016
Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial
Yuichi J Shimada, Christopher P Cannon, Yuyin Liu, et al.
Clinical Cardiology
|
June 15, 2021
Kidney outcomes using a sustained ≥40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trials
David Z I Cherney, Samuel Dagogo-Jack, Darren K McGuire, et al.
Sleep & Breathing = Schlaf & Atmung
|
May 20, 2022
Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial
Brian S Wojeck, Silvio E Inzucchi, Ian J Neeland, et al.
The American Journal of Cardiology
|
April 26, 2008
Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy
C Michael Gibson, Yuri B Pride, Jacqueline L Buros, et al.
Journal of the American Heart Association
|
October 30, 2018
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials
Antonio J Vallejo-Vaz, Henry N Ginsberg, Michael H Davidson, et al.
American Heart Journal
|
December 12, 2017
Association of insurance type with receipt of oral anticoagulation in insured patients with atrial fibrillation: A report from the American College of Cardiology NCDR PINNACLE registry
Celina M Yong, Yuyin Liu, Patricia Apruzzese, et al.
The American Journal of Cardiology
|
March 23, 2011
Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry)
Farhad Abtahian, Benjamin Olenchock, Fang-Shu Ou, et al.
Journal of the American Heart Association
|
August 9, 2021
What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry
Suzanne V Arnold, Christopher P Cannon, James A de Lemos, et al.
Page
of 71